BioInvent: New President and CEO
11.06.2013 - A Cancer antibody specialist BioInvent International AB (Lund) has named Michael Oredsson as its new President and CEO.
Oredsson, who will take up his post within the next six months, has wide experience in the pharma, biotech and nutrition sectors. The current CEO of Probi AB began his carreer with Mars and Nestlé, and previously held executive positions at Bio-signal in Australia and Nutri-pharma in Norway. He was also responsible for building up Pharmacia’s OTC product division in Australia.